骨同種異體移植市場－全球產業規模、佔有率、趨勢、機會和預測，按應用、按類型、按最終用戶、按地區和競爭進行細分，2020-2030 年預測

2024 年全球骨移植市場價值為 14.5 億美元，預計在預測期內將實現令人矚目的成長，到 2030 年的複合年成長率為 7.25%。近年來，受人口老化加劇、骨科疾病病例增加和醫療技術進步的推動，全球骨移植市場經歷了大幅成長。骨同種異體移植涉及將骨組織從捐贈者移植到接受者，已成為骨科和牙科手術的重要組成部分。骨同種異體移植是來自人類捐贈者的組織移植，可用於各種骨科和牙科應用。它們主要用於治療骨缺損、骨折、脊椎融合、關節重建和牙科手術。骨同種異體移植是自體移植（來自患者自身身體的骨組織）的可行替代方案，由於其能夠促進骨癒合、減輕疼痛和縮短恢復時間而廣受歡迎。根據 2024 年的一篇文章，估計英國 75 至 84 歲人口中約有 63% 患有肌肉骨骼疾病，是所有年齡層中患病率最高的。整體而言，肌肉骨骼疾病的盛行率隨著年齡的成長而上升，對老年人口的影響顯著。

骨關節炎、骨折、脊椎畸形等骨科疾病的全球盛行率正在上升。這種趨勢推動了對骨同種異體移植的需求，因為它們對於解決這些病症的外科手術至關重要。微創手術和機器人輔助手術等外科手術技術的進步增加了骨同種異體移植的採用。這些技術提高了骨移植手術的精確度和有效性。老化人口容易出現與年齡相關的骨骼問題，例如骨質疏鬆症和退化性關節疾病。隨著老齡人口不斷成長，預計骨同種異體移植的需求將大幅上升。嚴格的組織移植監管框架提高了骨移植的安全性和品質。這增強了消費者信心和市場成長。隨著患者和醫療專業人員對骨移植益處的認知不斷提高，此類移植在外科手術中的接受度和利用率也不斷提高。

主要市場促進因素

肌肉骨骼疾病發生率上升推動全球骨移植市場發展

主要市場挑戰

供應鏈約束

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球骨同種異體移植市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按應用分類（牙科、脊椎、重建和創傷學、其他）
  • 依類型（皮質骨同種異體移植、鬆質骨同種異體移植、皮質鬆質骨同種異體移植、脫礦骨基質）
  • 按最終使用者（醫院和牙科診所、骨科和創傷中心、其他）
  • 按地區
  • 按公司分類（前五大市場參與者的佔有率，2024 年）
• 市場地圖
  • 按應用
  • 按類型
  • 按最終用戶
  • 按地區

第 6 章：北美骨同種異體移植市場展望

• 市場規模和預測
• 市場佔有率和預測

第 7 章：歐洲骨同種異體移植市場展望

• 市場規模和預測
• 市場佔有率和預測

第 8 章：亞太地區骨移植市場展望

• 市場規模和預測
• 市場佔有率和預測

第 9 章：南美洲骨移植市場展望

• 市場規模和預測
• 市場佔有率和預測

第 10 章：中東和非洲骨移植市場展望

• 市場規模和預測
• 市場佔有率和預測

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 合併與收購
• 應用程式啟動

第 13 章：競爭格局

• Zimmer Biomet inc.
• Medtronic inc.
• Lynch Biologics, LLC
• Biomatlante SA
• Stryker Corporation
• Royal Biologics, Inc.
• Johnsons & Johnsons
• Smith & Nephew plc
• Baxter International Inc
• Xtant Medical Hldgs.

第 14 章：策略建議

第15章調查會社について,免責事項

The Global Bone Allografts Market was valued at USD 1.45 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.25% through 2030. The global bone allografts market has witnessed substantial growth in recent years, driven by an increasing aging population, rising cases of orthopedic disorders, and advancements in medical technology. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial part of orthopedic and dental procedures. Bone allografts are tissue grafts sourced from a human donor and are used for various orthopedic and dental applications. They are primarily employed in surgeries to treat bone defects, fractures, spinal fusion, joint reconstruction, and dental procedures. Bone allografts serve as a viable alternative to autografts (bone tissue from the patient's own body) and have gained popularity due to their ability to promote bone healing and reduce pain and recovery time. According to a 2024 article, an estimated 63% of individuals aged 75 to 84 in the United Kingdom were living with a musculoskeletal condition, the highest prevalence among all age groups. Overall, the prevalence of musculoskeletal conditions tends to rise with age, highlighting the significant impact on the elderly population.

The global prevalence of orthopedic disorders, including osteoarthritis, fractures, and spinal deformities, is on the rise. This trend has fueled the demand for bone allografts, as they are crucial in surgical interventions to address these conditions. Technological advancements in surgical techniques, such as minimally invasive surgeries and robotic-assisted procedures, have increased the adoption of bone allografts. These techniques enhance the precision and efficacy of bone grafting procedures. The aging population is prone to age-related bone issues, such as osteoporosis and degenerative joint diseases. As the elderly population continues to grow, the demand for bone allografts is expected to rise significantly. Stringent regulatory frameworks governing tissue transplantation have improved the safety and quality of bone allografts. This has bolstered consumer confidence and market growth. Increased awareness among both patients and healthcare professionals about the benefits of bone allografts has led to higher acceptance and utilization of these grafts in surgical procedures.

Key Market Drivers

Rising Incidence of Musculoskeletal Disorders is Driving the Global Bone Allografts Market

Musculoskeletal disorders have become a significant global health concern, affecting millions of people across the world. These disorders encompass a wide range of conditions that impact the muscles, bones, tendons, ligaments, and other parts of the musculoskeletal system. Conditions like osteoarthritis, osteoporosis, fractures, and spinal disorders have been on the rise due to various factors such as aging populations and sedentary lifestyles. To address the growing demand for musculoskeletal treatments, the global bone allografts market is experiencing remarkable growth.

Musculoskeletal disorders represent a wide spectrum of health issues, and their prevalence is increasing at an alarming rate globally. As the world's population ages, the incidence of musculoskeletal disorders, particularly osteoarthritis and osteoporosis, is rising. Aging leads to a natural loss of bone density and muscle mass, making individuals more susceptible to fractures and joint degeneration. Modern lifestyles often involve extended periods of sitting, limited physical activity, and poor posture. These factors can contribute to muscle imbalances and musculoskeletal problems, including back pain and repetitive strain injuries. Obesity is a significant risk factor for musculoskeletal disorders. Excess weight places additional stress on joints, leading to conditions like osteoarthritis and lower back pain. Jobs that involve repetitive motions, heavy lifting, or prolonged periods of standing can lead to musculoskeletal injuries. Workers in industries like construction, healthcare, and manufacturing are at a higher risk. Participation in sports and physical activities carries a risk of injury, including fractures and ligament tears, which can contribute to the overall burden of musculoskeletal disorders.

Key Market Challenges

Supply Chain Constraints

One of the primary challenges facing the bone allografts market is the consistent and reliable supply of graft materials. The availability of suitable donor tissues can be affected by factors such as changes in regulations, limitations on donor pool size, and disruptions in the supply chain due to natural disasters or health crises like the COVID-19 pandemic. Ensuring a stable supply chain is essential to meet the growing demand for bone allografts.

Key Market Trends

Technological Advancements

Technological advancements have always been a catalyst for innovation and growth in various industries, and the healthcare sector is no exception. In recent years, the global bone allografts market has witnessed a remarkable surge in demand, thanks to the continuous evolution of cutting-edge technologies. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial component in various orthopedic and dental procedures. Also, the partnership between two companies leads to the growth of global bone allografts market. For instance, in August 2022, Orthofix Medical Inc., a medical device company, collaborated with CGBio, a developer of synthetic bone grafts, to commercialize and advance the clinical development of Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) in the U.S. and Canadian markets.

Key Market Players

• Zimmer Biomet inc.
• Medtronic inc.
• Lynch Biologics, LLC
• Biomatlante S.A
• Stryker Corporation
• Royal Biologics, Inc.
• Johnsons & Johnsons
• Smith & Nephew plc
• Baxter International Inc
• Xtant Medical Hldgs.

Report Scope:

In this report, the Global Bone Allografts Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Allografts Market, By Application:

• Dental
• Spine
• Reconstruction & Traumatology
• Others

Bone Allografts Market, By Type:

• Cortical Bone Allografts
• Cancellous Bone Allografts
• Corticocancellous Bone Allografts
• Demineralized bone Matrices

Bone Allografts Market, By End-user:

• Hospitals & Dental Clinics
• Orthopedic & Trauma Centers
• Others

Bone Allografts Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone Allografts Market.

Available Customizations:

Global Bone Allografts market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Allografts Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Dental, Spine, Reconstruction & Traumatology, Others)
  • 5.2.2. By Type (Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, Demineralized bone Matrices)
  • 5.2.3. By End-user (Hospitals & Dental Clinics, Orthopedic & Trauma Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (Shares of Top 5 Market Players, 2024)
• 5.3. Market Map
  • 5.3.1. By Application
  • 5.3.2. By Type
  • 5.3.3. By End user
  • 5.3.4. By Region

6. North America Bone Allografts Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Type
  • 6.2.3. By End user
  • 6.2.4. By Country
    • 6.2.4.1. United States Bone Allografts Market Outlook
      • 6.2.4.1.1. Market Size & Forecast
      • 6.2.4.1.1.1. By Value
      • 6.2.4.1.2. Market Share & Forecast
      • 6.2.4.1.2.1. By Application
      • 6.2.4.1.2.2. By Type
      • 6.2.4.1.2.3. By End user
    • 6.2.4.2. Canada Bone Allografts Market Outlook
      • 6.2.4.2.1. Market Size & Forecast
      • 6.2.4.2.1.1. By Value
      • 6.2.4.2.2. Market Share & Forecast
      • 6.2.4.2.2.1. By Application
      • 6.2.4.2.2.2. By Type
      • 6.2.4.2.2.3. By End user
    • 6.2.4.3. Mexico Bone Allografts Market Outlook
      • 6.2.4.3.1. Market Size & Forecast
      • 6.2.4.3.1.1. By Value
      • 6.2.4.3.2. Market Share & Forecast
      • 6.2.4.3.2.1. By Application
      • 6.2.4.3.2.2. By Type
      • 6.2.4.3.2.3. By End user

7. Europe Bone Allografts Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Type
  • 7.2.3. By End user
  • 7.2.4. By Country
    • 7.2.4.1. France Bone Allografts Market Outlook
      • 7.2.4.1.1. Market Size & Forecast
      • 7.2.4.1.1.1. By Value
      • 7.2.4.1.2. Market Share & Forecast
      • 7.2.4.1.2.1. By Application
      • 7.2.4.1.2.2. By Type
      • 7.2.4.1.2.3. By End user
    • 7.2.4.2. Germany Bone Allografts Market Outlook
      • 7.2.4.2.1. Market Size & Forecast
      • 7.2.4.2.1.1. By Value
      • 7.2.4.2.2. Market Share & Forecast
      • 7.2.4.2.2.1. By Application
      • 7.2.4.2.2.2. By Type
      • 7.2.4.2.2.3. By End user
    • 7.2.4.3. United Kingdom Bone Allografts Market Outlook
      • 7.2.4.3.1. Market Size & Forecast
      • 7.2.4.3.1.1. By Value
      • 7.2.4.3.2. Market Share & Forecast
      • 7.2.4.3.2.1. By Application
      • 7.2.4.3.2.2. By Type
      • 7.2.4.3.2.3. By End user
    • 7.2.4.4. Italy Bone Allografts Market Outlook
      • 7.2.4.4.1. Market Size & Forecast
      • 7.2.4.4.1.1. By Value
      • 7.2.4.4.2. Market Share & Forecast
      • 7.2.4.4.2.1. By Application
      • 7.2.4.4.2.2. By Type
      • 7.2.4.4.2.3. By End user
    • 7.2.4.5. Spain Bone Allografts Market Outlook
      • 7.2.4.5.1. Market Size & Forecast
      • 7.2.4.5.1.1. By Value
      • 7.2.4.5.2. Market Share & Forecast
      • 7.2.4.5.2.1. By Application
      • 7.2.4.5.2.2. By Type
      • 7.2.4.5.2.3. By End user

8. Asia Pacific Bone Allografts Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Type
  • 8.2.3. By End user
  • 8.2.4. By Country
    • 8.2.4.1. China Bone Allografts Market Outlook
      • 8.2.4.1.1. Market Size & Forecast
      • 8.2.4.1.1.1. By Value
      • 8.2.4.1.2. Market Share & Forecast
      • 8.2.4.1.2.1. By Application
      • 8.2.4.1.2.2. By Type
      • 8.2.4.1.2.3. By Application
    • 8.2.4.2. India Bone Allografts Market Outlook
      • 8.2.4.2.1. Market Size & Forecast
      • 8.2.4.2.1.1. By Value
      • 8.2.4.2.2. Market Share & Forecast
      • 8.2.4.2.2.1. By Application
      • 8.2.4.2.2.2. By Type
      • 8.2.4.2.2.3. By End user
    • 8.2.4.3. South Korea Bone Allografts Market Outlook
      • 8.2.4.3.1. Market Size & Forecast
      • 8.2.4.3.1.1. By Value
      • 8.2.4.3.2. Market Share & Forecast
      • 8.2.4.3.2.1. By Application
      • 8.2.4.3.2.2. By Type
      • 8.2.4.3.2.3. By End user
    • 8.2.4.4. Japan Bone Allografts Market Outlook
      • 8.2.4.4.1. Market Size & Forecast
      • 8.2.4.4.1.1. By Value
      • 8.2.4.4.2. Market Share & Forecast
      • 8.2.4.4.2.1. By Application
      • 8.2.4.4.2.2. By Type
      • 8.2.4.4.2.3. By End user
    • 8.2.4.5. Australia Bone Allografts Market Outlook
      • 8.2.4.5.1. Market Size & Forecast
      • 8.2.4.5.1.1. By Value
      • 8.2.4.5.2. Market Share & Forecast
      • 8.2.4.5.2.1. By Application
      • 8.2.4.5.2.2. By Type
      • 8.2.4.5.2.3. By End user

9. South America Bone Allografts Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Type
  • 9.2.3. By End user
  • 9.2.4. By Country
    • 9.2.4.1. Brazil Bone Allografts Market Outlook
      • 9.2.4.1.1. Market Size & Forecast
      • 9.2.4.1.1.1. By Value
      • 9.2.4.1.2. Market Share & Forecast
      • 9.2.4.1.2.1. By Application
      • 9.2.4.1.2.2. By Type
      • 9.2.4.1.2.3. By End user
    • 9.2.4.2. Argentina Bone Allografts Market Outlook
      • 9.2.4.2.1. Market Size & Forecast
      • 9.2.4.2.1.1. By Value
      • 9.2.4.2.2. Market Share & Forecast
      • 9.2.4.2.2.1. By Application
      • 9.2.4.2.2.2. By Type
      • 9.2.4.2.2.3. By End user
    • 9.2.4.3. Colombia Bone Allografts Market Outlook
      • 9.2.4.3.1. Market Size & Forecast
      • 9.2.4.3.1.1. By Value
      • 9.2.4.3.2. Market Share & Forecast
      • 9.2.4.3.2.1. By Application
      • 9.2.4.3.2.2. By Type
      • 9.2.4.3.2.3. By End user

10. Middle East & Africa Bone Allografts Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Type
  • 10.2.3. By End user
  • 10.2.4. By Country
    • 10.2.4.1. South Africa Bone Allografts Market Outlook
      • 10.2.4.1.1. Market Size & Forecast
      • 10.2.4.1.1.1. By Value
      • 10.2.4.1.2. Market Share & Forecast
      • 10.2.4.1.2.1. By Application
      • 10.2.4.1.2.2. By Type
      • 10.2.4.1.2.3. By End user
    • 10.2.4.2. Saudi Arabia Bone Allografts Market Outlook
      • 10.2.4.2.1. Market Size & Forecast
      • 10.2.4.2.1.1. By Value
      • 10.2.4.2.2. Market Share & Forecast
      • 10.2.4.2.2.1. By Application
      • 10.2.4.2.2.2. By Type
      • 10.2.4.2.2.3. By End user
    • 10.2.4.3. UAE Bone Allografts Market Outlook
      • 10.2.4.3.1. Market Size & Forecast
      • 10.2.4.3.1.1. By Value
      • 10.2.4.3.2. Market Share & Forecast
      • 10.2.4.3.2.1. By Application
      • 10.2.4.3.2.2. By Type
      • 10.2.4.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Application Launches

13. Competitive Landscape

• 13.1. Zimmer Biomet inc.
• 13.2. Medtronic inc.
• 13.3. Lynch Biologics, LLC
• 13.4. Biomatlante S.A
• 13.5. Stryker Corporation
• 13.6. Royal Biologics, Inc.
• 13.7. Johnsons & Johnsons
• 13.8. Smith & Nephew plc
• 13.9. Baxter International Inc
• 13.10. Xtant Medical Hldgs.

14. Strategic Recommendations

15. About us & Disclaimer